FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

Dated August 8, 2005

BIOMIRA INC.

(Translation of registrant’s name into English)

Edmonton Research Park

2011-94 Street, Edmonton, Alberta Canada T6N1H1

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ý (for past years ending in calendar year 1996)

Form 40-F ý (commencing in calendar year 1997)

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o

No ý

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

TABLE OF CONTENTS

Item	Page

Quarterly Report of the Company mailed to Shareholders on or about August 5, 2005 (Note that only the cover page of the Report is attached because the balance of the Report is identical to the earnings press release filed with a Form 6-K on July 27, 2005, except only that the heading on the first page has been changed from “NEWS RELEASE FOR IMMEDIATE RELEASE” to “SECOND QUARTER REPORT” and opposite that heading on the left side the Company's address and website have been added on the right side, as follows "2011-94 Street, Edmonton, Alberta T6N 1H1 Web site: www.biomira.com)		3

Canadian Certification of the Company’s Chief Executive Officer of Interim Filings During the Transition Period (Form 52-109 FT2) filed on SEDAR on August 5, 2005		4

Canadian Certification of the Company’s Chief Financial Officer of Interim Filings During the Transition Period (Form 52-109 FT2) filed on SEDAR on August 5, 2005		5

Signature		6

Biomira Inc.

2011-94 Street

Edmonton, AB T6N 1H1

June 2005 Second Quarter Report

Trading Information:	NASDAQ National Market (symbol “BIOM”)
	The Toronto Stock Exchange (symbol “BRA”)

For Information Contact:	Edward Taylor
	Vice President Finance and Administration/Chief
	Financial Officer

	Jane Tulloch
	Director, Investor Relations & Compliance Officer

E-Mail:	ir@biomira.com

Web:	www.biomira.com

Biomira: The Cancer Vaccine PeopleÔ

Form 52-109FT2 - Certification of Interim Filings during Transition Period

I, T. Alexander McPherson, MD, PhD., President and CEO, certify that:

1.	I have reviewed the interim filings (as this term is defined in Multilateral Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings) of Biomira Inc. for the quarter ending June 30, 2005;

2.	Based on my knowledge, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings; and

3.	Based on my knowledge, the interim financial statements together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of the date and for the periods presented in the interim filings.

August 5, 2005

/s/ T. Alexander McPherson

T. Alexander McPherson

President and CEO

Form 52-109FT2 - Certification of Interim Filings during Transition Period

I, Edward A. Taylor, Vice President Finance and Administration and Chief Financial Officer, certify that:

1.	I have reviewed the interim filings (as this term is defined in Multilateral Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings) of Biomira Inc. for the quarter ending June 30, 2005;

2.	Based on my knowledge, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings; and

3.	Based on my knowledge, the interim financial statements together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of the date and for the periods presented in the interim filings.

August 5, 2005

/s/ Edward A. Taylor

Edward A. Taylor

Vice President, Finance & Administration

and Chief Financial Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIOMIRA INC.
	(Registrant)


Date: August 8, 2005	By:	/s/ Edward A. Taylor
		Edward A. Taylor
		Vice President, Finance & Administration
		and Chief Financial Officer

BIOMIRA INC 6-K